Empreendimentos Pague Menos (PGMN3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Mar, 2026Executive summary
Achieved record-breaking operational and financial results in 2025, with five consecutive quarters of same-store sales growth above 17% and strong momentum across all key metrics, especially in the North and Northeast.
Underwent a profound transformation and strategic repositioning over the past two years, driving operational excellence, digital transformation, and investment resumption.
Maintained a transparent, people-centric strategy, strengthening organizational culture, employee satisfaction, and stakeholder perception.
Financial highlights
Gross revenue grew 19.8% year-over-year to R$16,049 million in 2025, with same-store sales up 18.6% in Q4 and five consecutive quarters above 17%.
Adjusted EBITDA reached R$904.7 million (margin 5.6%), nearly doubling in two years, and adjusted net income rose to R$286.6 million, up over 70% year-over-year.
Free cash flow improved by R$323 million over two years, reaching R$212.1 million in 2025.
Net debt/EBITDA reduced to 2.0x, down from 4.3x in 2023, and ROIC increased by 9.3 percentage points to 21%.
Outlook and guidance
2026 is positioned as the "year of scale," focusing on expanding logistics, digital channels, private brands, and launching new projects such as Store 4.0.
Strategic plan maturation, organizational efficiency, and further productivity gains are priorities, with generics and similars for GLP-1 drugs expected to drive volume and reduce receivables pressure.
Nearly one-third of CAPEX allocated to logistics improvements, with commitment to further deleveraging and cash generation.
Latest events from Empreendimentos Pague Menos
- Revenue and profit surged on strong sales, margin expansion, and synergy capture.PGMN3
Q2 20242 Feb 2026 - Record sales, margin gains, and lower leverage highlight strong operational momentum.PGMN3
Q3 202416 Jan 2026 - Record sales, margin expansion, and synergy capture drive robust growth and deleveraging.PGMN3
Q4 202419 Dec 2025 - Record sales and profit growth fueled by digital and operational gains.PGMN3
Q2 202523 Nov 2025 - Record revenue and EBITDA growth, digital acceleration, and market share gains in Q1 2025.PGMN3
Q1 202519 Nov 2025 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 202513 Nov 2025 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation3 Jul 2025 - Nationwide Health Hub and digital innovation fuel PagueMenos extrafarma’s rapid, profitable growth.PGMN3
Investor Presentation16 Jun 2025